Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 321

1.
2.

A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.

Gaspar LE, Qian C, Kocha WI, Coia LR, Herskovic A, Graham M.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):593-9.

PMID:
9112458
4.

Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.

Brunner TB, Rupp A, Melzner W, Grabenbauer GG, Sauer R.

Strahlenther Onkol. 2008 Jan;184(1):15-22. doi: 10.1007/s00066-008-1787-5.

PMID:
18188518
5.

Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.

Calais G, Dorval E, Louisot P, Bourlier P, Klein V, Chapet S, Reynaud-Bougnoux A, Huten N, De Calan L, Aget H, Le Floch O.

Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):769-75.

PMID:
9240645
6.

High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.

Yorozu A, Dokiya T, Oki Y.

Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):271-5.

PMID:
10487545
8.

Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.

Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):982-7.

PMID:
11704321
9.

The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.

Vuong T, Szego P, David M, Evans M, Parent J, Mayrand S, Corns R, Burtin P, Faria S, Devic S.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):758-64.

PMID:
16199311
10.

High dose rate brachytherapy for superficial cancer of the esophagus.

Maingon P, d'Hombres A, Truc G, Barillot I, Michiels C, Bedenne L, Horiot JC.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):71-6.

PMID:
10656375
11.

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.

Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD.

Cancer J. 2003 Jul-Aug;9(4):251-60.

PMID:
12967135
12.

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.

Sood BM, Gorla G, Gupta S, Garg M, Deore S, Runowicz CD, Fields AL, Goldberg GL, Anderson PS, Vikram B.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):702-6.

PMID:
12062615
13.

Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.

Coia LR, Engstrom PF, Paul A.

J Clin Oncol. 1987 Nov;5(11):1783-90.

PMID:
2445931
14.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
15.

Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.

Forastiere AA, Heitmiller RF, Lee DJ, Zahurak M, Abrams R, Kleinberg L, Watkins S, Yeo CJ, Lillemoe KD, Sitzmann JV, Sharfman W.

Cancer J Sci Am. 1997 May-Jun;3(3):144-52.

PMID:
9161779
16.

Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.

Stuschke M, Stahl M, Wilke H, Walz M, Oldenburg A, Stüben G, Seeber S, Sack H.

Am J Clin Oncol. 2000 Jun;23(3):233-8.

PMID:
10857883
17.

Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study.

Servagi-Vernat S, Bosset M, Crehange G, Buffet-Miny J, Puyraveau M, Maingon P, Mercier M, Bosset JF.

Drugs Aging. 2009;26(3):255-62. doi: 10.2165/00002512-200926030-00006.

PMID:
19358620
18.
19.

Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):111-22.

PMID:
15337546
20.

Concurrent chemoradiotherapy for squamous cell carcinoma of thoracic esophagus: feasibility and outcome of large regional field and high-dose external beam boost irradiation.

Toita T, Ogawa K, Adachi G, Kakinohana Y, Nishikuramori Y, Iraha S, Utsunomiya T, Murayama S.

Jpn J Clin Oncol. 2001 Aug;31(8):375-81.

Items per page

Supplemental Content

Write to the Help Desk